Sakai Chemical Industry Co., Ltd. · TSE:4078
Sakai Chemical Industry — 1H FY03/27 Earnings Presentation
48 slides from Sakai Chemical Industry's earnings presentation, Nov 17, 2026
Slide 1: Interim Financial Results Presentation for the Fiscal Year Ending March 31, 2027
SAKAI CHEMICAL INDUSTRY CO., LTD. Interim Financial Results Presentation for the Fiscal Year Ending March 31, 2027 November 9, 2026 [TSE Prime; Securities Code: 4078]
Slide 2: Key Points of This Presentation
Key Points of This Presentation ➢ Progress exceeded plans • Electronic materials: Performed strongly by capturing AI data center-related demand. • Hygienic products: New projects secured and cost reduction measures contributed. • Contract processing: Sales mix improved, supported by shipments of hig
Slide 3: 1H FY03/27 Results Summary
1H FY03/27 Results Summary SAKAI CHEMICAL INDUSTRY CO., LTD. 3
Slide 4: 1H FY03/27 Results Summary
1H FY03/27 Results Summary ● YoY performance ― Net sales: +6.6% / operating profit: +6.3% Contributions from the various businesses offset the impact from the termination of the pigment-grade titanium dioxide business, securing YoY growth in net sales and profit. Growth businesses and other business
Slide 5: 1H FY03/27 Results Overview (YoY, Versus Plan)
1H FY03/27 Results Overview (YoY, Versus Plan) (Millions of yen) 1H FY03/26 Actual 1H FY03/27 Actual YoY Change 1H FY03/27 plan Versus plan Amount % Amount % Amount % Amount % Amount % Net sales 40,353 ー 43,000 ー 2,647 6.6 41,700 ー 1,300 3.1 Operating profit 3,284 8.1 3,489 8.1 205 6.3 3,100 7.4 389
Slide 6: Factors Behind YoY Change in Operating Profit
Factors Behind YoY Change in Operating Profit (Millions of yen) 7,500 286 -3,643 3,775 6,500 5,500 -96 -18 -34 -65 4,500 3,500 3,284 3,489 2,500 1H FY03/26 Change in per- Change in Change in Change in Change in Change in Others 1H FY03/27 unit selling sales volume per-unit fuel and personnel and dep
Slide 7: Factors Behind Operating Profit Variance (Versus Initial Forecast)
Factors Behind Operating Profit Variance (Versus Initial Forecast) (Millions of yen) 4,500 140 -1,024 1,083 4,000 153 28 46 -37 3,500 3,000 3,489 3,100 2,500 Initial FY03/27 Change in per-unit Change in Change in Change in Change in Change in Others 1H FY03/27 forecast selling prices sales volume pe
Slide 8: Balance Sheet Comparison
Balance Sheet Comparison Consolidated B/S (Millions of yen) FY03/26 1H FY03/27 Change [Key Factors Driving Change] Cash and deposits 15,502 15,063 -439 Notes and accounts receivable - trade 25,056 25,694 638 • Non-current assets / Other: +1,953 million yen Increase due to valuation differences on in
Slide 9: Cash Flow Statement Comparison
Cash Flow Statement Comparison 1H 1H Summary Consolidated C/F (Millions of yen) Change FY03/26 FY03/27 Investing cash outflows decreased as a round of Beginning cash and cash equivalents balance 16,153 15,444 -708 capital investment was completed, increasing FCF Profit (loss) before income taxes 4,3
Slide 10: Operating Profit by Segment (Versus 1H FY03/26)
Operating Profit by Segment (Versus 1H FY03/26) Operating profit by segment (millions of yen) 1H FY03/26 1H FY03/27 Change Growth businesses 1,300 1,423 122 Electronic materials 1,014 1,141 127 Cosmetic materials (215) (244) -28 Organic chemicals 502 525 23 Stable businesses 533 809 276 Hygienic pro
Slide 11: Operating Profit by Segment (YoY Change)
Operating Profit by Segment (YoY Change) 3,800 276 -87 86 -135 -57 122 3,400 3,489 3,284 3,000 Businesses Growth Stable Companywide 1H FY03/26 under Medical Others 1H FY03/27 businesses businesses expenses efficiency review (Millions of yen) ➢ Growth businesses and stable businesses drove profit gro
Slide 12: FY03/27 Earnings Forecast
FY03/27 Earnings Forecast SAKAI CHEMICAL INDUSTRY CO., LTD. 12
Slide 13: FY03/27 Earnings Forecast
FY03/27 Earnings Forecast ➢ In 2H, electronic materials are expected to continue performing strongly, but net sales and profit are projected to decline compared with 1H due to an anticipated decrease in sales of pigment-grade titanium dioxide inventory and deterioration in the sales mix in the previ
Slide 14: Business Environment Overview (Excluding the Situation in the Middle East)
Business Environment Overview (Excluding the Situation in the Middle East) Segment Assumptions for FY03/27 forecast (as of May 2026) Assumptions for FY03/27 forecast (as of November 2026) Electronic • We project ongoing favorable performance from AI data center- • Business related to AI data centers
Slide 15: Forecasts by Segment (Versus FY03/26 Results)
Forecasts by Segment (Versus FY03/26 Results) (Millions of yen) FY03/26 results Revised FY03/27 forecast Difference Operating Operating Sales OPM Sales OPM Sales Operating profit profit profit Amount Amount % Amount Amount % Amount % Amount % Electronic materials 11,377 1,816 16.0 12,800 2,600 20.3
Slide 16: Forecasts by Segment (Versus Initial Forecast)
Forecasts by Segment (Versus Initial Forecast) (Millions of yen) Initial FY03/27 forecast Revised FY03/27 forecast Difference Operating Operating Sales OPM Sales OPM Sales Operating profit profit profit Amount Amount % Amount Amount % Amount % Amount % Electronic materials 11,500 2,400 20.9 12,800 2
Slide 17: Revised FY03/27 Forecast: Operating Profit by Segment (YoY Change)
Revised FY03/27 Forecast: Operating Profit by Segment (YoY Change) 8,000 238 -1,138 1,100 7,500 7,000 -152 102 -100 6,500 6,452 6,500 6,000 FY03/26 Growth Stable Businesses under Companywide Revised FY03/27 Medical Other expenses forecast results businesses businesses efficiency review (Millions of
Slide 18: Revised FY03/27 Forecast: Operating Profit by Segment (Versus Initial Forecast)
Revised FY03/27 Forecast: Operating Profit by Segment (Versus Initial Forecast) 7,000 100 -300 300 0 6,500 200 200 6,000 6,500 6,000 5,500 Initial FY03/27 Growth Stable Businesses under Companywide Revised FY03/27 Medical Other expenses forecast (Millions of yen) forecast businesses businesses effic
Slide 19: Trends in CAPEX, Depreciation, and R&D Expenses
Trends in CAPEX, Depreciation, and R&D Expenses (Millions of yen) FY03/27 FY03/22 FY03/23 FY03/24 FY03/25 FY03/26 1H FY03/27 forecast CAPEX 5,967 2,658 4,024 6,945 6,065 5,400 2,246 Depreciation 4,331 4,417 4,354 3,649 3,735 4,000 1,905 R&D 2,376 2,674 2,722 2,699 2,842 3,300 1,433 Capital Investmen
Slide 20: Shareholder Returns
Shareholder Returns ➢ The annual dividend remains unchanged from the previously announced forecast. An annual dividend of 160 yen per share is planned (interim dividend: 80 yen/share, year-end dividend: 80 yen/share; forecast DOE: over 3%). (Yen) DPR DOE Interim dividend 中間配当(円/株) Year-end dividend
Slide 21: Exercise of the Stock Acquisition Rights and Issuance of New Shares
Exercise of the Stock Acquisition Rights and Issuance of New Shares (Subsequent Events) ➢ The allottee (SH1, L.P.) requested full exercise of the Fourth Series Stock Acquisition Rights issued in June 2023. The exercise was completed and the new shares were issued by October 26, 2026. ➢ The Company p
Slide 22: Reportable Segment Details for FY03/27
Reportable Segment Details for FY03/27 SAKAI CHEMICAL INDUSTRY CO., LTD. 22
Slide 23: Relationships Between Former and Current Segments
Relationships Between Former and Current Segments Former Former sub- Current segments segments segments FY03/24 Definitions for Business Portfolio Transformation FY03/25 → FY03/27 Electronic Positioned as drivers of mid- to long-term Electronic Growth materials profit growth, with an accelerated foc
Slide 24: Growth Businesses: Electronic Materials
Growth businesses Electronic Materials ● YoY Comparison (Millions of yen) ● YoY Comparison 1H FY03/26 1H FY03/27 Change (+) Increased sales volumes of high-value-added products Although overall sales volumes remained largely unchanged, strong Sales Amount % Amount % Amount % shipments of high-value-
Slide 25: Growth Businesses: Cosmetic Materials
Growth businesses Cosmetic Materials ● YoY Comparison (Millions of yen) ● YoY Comparison 1H FY03/26 1H FY03/27 Change (+) Recovery in sales volumes Sales Amount % Amount % Amount % Although domestic sales continued to be affected by the economic slowdown in China, overseas shipment volumes recovered
Slide 26: Growth Businesses: Organic Chemicals
Growth businesses Organic Chemicals ● YoY Comparison (Millions of yen) ● YoY Comparison 1H FY03/26 1H FY03/27 Change (+) Increased sales volumes (organic sulfur compounds) Sales Amount % Amount % Amount % Although sales volumes of pharmaceutical API intermediates remained unchanged, increased sales
Slide 27: Stable Businesses: Hygienic Products
Stable businesses Hygienic Products ● YoY Comparison (Millions of yen) ● YoY Comparison 1H FY03/26 1H FY03/27 Change (+) Increased sales volumes Sales Amount % Amount % Amount % Sales increased as sales volumes of lower-cost films grew in the breathable film manufacturing and sales business in Indon
Slide 28: Stable Businesses: Contract Processing
Stable businesses Contract Processing ● YoY Comparison (Millions of yen) ● YoY Comparison 1H FY03/26 1H FY03/27 Change (+) Sales volume growth Sales Amount % Amount % Amount % Strong sales mainly to existing customers in both processed pigments and contract processing resulted in higher sales. Sales
Slide 29: Titanium Dioxide and Zinc Products
Titanium Dioxide and Zinc Products Businesses under (Excluding Cosmetic Materials) efficiency review ● YoY Comparison (Millions of yen) ● YoY Comparison 1H FY03/26 1H FY03/27 Change (-) Sales volume decline due to termination of the pigment- grade titanium dioxide business Sales Amount % Amount % Am
Slide 30: Plastic Additives
Businesses under Plastic Additives efficiency review ● YoY Comparison (Millions of yen) ● YoY Comparison 1H FY03/26 1H FY03/27 Change (+) Selling price revisions (domestic), sales volume growth (overseas) Amount % Amount % Amount % Domestic sales increased as selling price revisions to reflect highe
Slide 31: Catalysts
Businesses under Catalysts efficiency review ● YoY Comparison (Millions of yen) ● YoY Comparison 1H FY03/26 1H FY03/27 Change (+) Sales volume growth (nickel catalysts) Although sales volumes of deNOx catalysts declined as some sales Sales Amount % Amount % Amount % were carried over to 2H, sales vo
Slide 32: Barium
Businesses under Barium efficiency review ● YoY Comparison (Millions of yen) ● YoY Comparison 1H FY03/26 1H FY03/27 Change (+) Sales volume growth Steady sales of mainstay barium products for paints and inks and Sales Amount % Amount % Amount % products under development (zirconium oxide dispersions
Slide 33: Medical
Medical Medical ● YoY Comparison (Millions of yen) ● YoY Comparison 1H FY03/26 1H FY03/27 Difference (-) Impact of drug price reductions and lower unit sales of medical devices Amount % Amount % Amount % In prescription pharmaceuticals, export sales of mainstay barium Sales contrast agents grew, but
Slide 34: Reference Materials
Reference Materials • Company Profile • Our Businesses • Performance Trends, etc. SAKAI CHEMICAL INDUSTRY CO., LTD. 34
Slide 35: Sakai Chemical Industry Co., Ltd. Company Profile
Sakai Chemical Industry Co., Ltd. Company Profile Head office 5-2, Ebisujima-cho, Sakai-ku, Sakai-shi, Osaka Representative President and Representative Director, Toshiyuki Yagura Established June 1918 Inorganic chemical, organic chemical, and pharmaceutical Businesses development, manufacture, and
Slide 36: Relationships Between Group Companies and Reportable Segments
Relationships Between Group Companies and Reportable Segments Titanium Electronic Cosmetic Organic Hygienic Contract dioxide Plastic materials materials chemicals products processing and zinc additives Catalysts Barium Medical Others products Sakai Chemical Industry Co., Ltd. ● ● ● ● ● ● ● ● Sakai T
Slide 37: Sakai Group Products in Everyday Life
Sakai Group Products in Everyday Life Waste Incinerators Hospitals ・X-ray barium contrast media ・deNOx catalyst ・Alloid G ・Dioxin decomposition catalyst ・Medical devices Automobiles ・Dielectrics and dielectric materials for MLCC ・Titanium dioxide and barium sulfate for Housing ・PVC window sash stabi
Slide 38: Changes in Segment Reporting
Changes in Segment Reporting Objective Following our full acquisition of Sakai Trading Co., Ltd., we aim to facilitate clearer understanding of our business structure while enabling management and disclosure of segment information more reflective of actual business conditions. (1) The Chemicals busi
Slide 39: Improvement in Cash Conversion Cycle: Medium-Term Management Plan Progress
Improvement in Cash Conversion Cycle: Progress of Medium-Term Management Plan “Transformation: BEYOND 2030” ■ Cash conversion cycle target: 180 days or less Target cumulative three-year monetary impact of 7.0 billion yen (by end-FY03/27) ➢ Compared to FY03/24, CCC shortened by 52 days to 164 days, w
Slide 40: Quarterly Performance (Former Reportable Segment Structure)
Quarterly Performance (Former Reportable Segment Structure) セグメント業績推移(四半期) (Segment Performance Trends (Base on Quarterly) 単位:百万円 (Unit : Million Yen) 26.3期(FY 2025) 27.3期(FY 2026) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 電子材料 売上高 Net Sales 2,870 2,976 2,821 2,708 3,364 3,013 Electronic materials 営業利益 Operating Prof
Slide 41: Our Businesses: Electronic Materials
Our Businesses Electronic Materials Multilayer ceramic capacitors ・Dielectric (barium titanate) Dielectrics ・Dielectric materials (high-purity barium carbonate) Electrodes A primary material for multilayer ceramic capacitors essential for electronic devices. A property of dielectrics is that they ca
Slide 42: Our Businesses: Cosmetic and Organic Materials
Our Businesses Cosmetic Materials Sunscreens, foundations, • Cosmetic materials: Achieve high UV blocking and smooth skin texture Used in places like these Organic Materials Plastic lenses, concrete, lubricants, pharmaceuticals • Organic sulfur compounds: Improves refractive index of eyeglass Used i
Slide 43: Our Businesses: Hygienic Products and Contract Processing
Our Businesses Hygienic Products Diapers, feminine hygiene products ・Breathable films: Retain moisture and allow only air to pass Used in places like these Amid increasing demand overseas, our Indonesian subsidiary manufactures breathable films. Contract Processing Contracted manufacturing of inorga
Slide 44: Our Businesses: Plastic Additives
Our Businesses Plastic Additives Pipes, joints, window frames, wallpapers, wire harnesses • PVC stabilizers/non-PVC stabilizers • Hydrotalcite: Used in lead-free PVC stabilizers and agricultural films due to its high heat retention and transparency PVC stabilizers are added to improve the processabi
Slide 45: Our Businesses: Titanium Dioxide, Zinc Products and Catalysts
Our Businesses Titanium Dioxide and Zinc Products • Titanium dioxide: A white pigment with excellent coloring, concealing, weather resistance, and chemical stability • Zinc oxide: A vulcanization accelerator for rubber products Used in places like these Titanium dioxide is a material necessary in al
Slide 46: Our Businesses: Barium
Our Businesses Barium ・Barium sulfate ・Strontium salts ・Zirconium oxide dispersion, etc. One of our specialties is barium sulfate, which is blended into various coatings, inks, and films, supporting essential functions such as enhancing aesthetic appeal and improving heat resistance. We also work wi
Slide 47: Our Businesses (Medical)
Our Businesses (Medical) Kaigen Pharma Co., Ltd. X-ray barium contrast media Medical devices Used in gastrointestinal imaging ・Endoscope washing / disinfection equipment Manufacture of the raw medicinal material barium Adapting to the shift from barium to sulfate commenced in 1931. This familiar exa
Slide 48: We appreciate your kind attention.
We appreciate your kind attention. This document is provided solely for informational purposes and is not intended to solicit any specific actions. This document (including performance plans) was created by Sakai Chemical based on available data and includes predictive statements subject to various
Sakai Chemical Industry — 1H FY03/27 Earnings Presentation on 6ix